Sandoz Group (OTCMKTS:SDZNY) Trading Up 1% – Still a Buy?

Sandoz Group AG (OTCMKTS:SDZNY)’s share price rose 1% during mid-day trading on Thursday . The company traded as high as $42.49 and last traded at $41.71. Approximately 19,907 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 92,822 shares. The stock had previously closed at $41.31.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. BNP Paribas cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, December 2nd. Royal Bank of Canada downgraded shares of Sandoz Group from a “moderate buy” rating to a “hold” rating in a research note on Monday, September 16th.

Sandoz Group Trading Down 1.3 %

The business has a 50-day moving average of $43.98 and a two-hundred day moving average of $41.72.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.